DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology

Kuo Y.-J.Lewis J.S.Jr.Zhai C.Chen Y.-A.Chernock R.D.MIN-SHU HSIEHLan M.-Y.Lee C.-K.Weinreb I.Hang J.-F.2022-01-082022-01-0820210893-3952https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107442724&doi=10.1038%2fs41379-021-00846-2&partnerID=40&md5=d306fe18a31b14d76c8e893aec499769https://scholars.lib.ntu.edu.tw/handle/123456789/591930A novel DEK-AFF2 fusion has been recently identified in four cases of basaloid to nonkeratinizing squamous cell carcinoma (SCC) in the sinonasal tract and middle ear with high-grade morphology. The exceptional response to immune checkpoint inhibitor in th[SDGs]SDG3epidermal growth factor receptor; immune checkpoint inhibitor; K ras protein; protein p40; protein p63; adult; aged; Article; cancer morphology; carcinoma in situ; chemoradiotherapy; clinical article; clinical feature; DEK AFF2 gene fusion; disease courseDEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphologyjournal article10.1038/s41379-021-00846-2341086362-s2.0-85107442724